Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice

PURPOSE: The purpose of this study was to evaluate 2-year visual outcomes in patients with diabetic macular edema (DME) treated with anti-VEGF agents in a routine clinical setting. METHODS: The medical records of patients treated with ranibizumab or aflibercept due to DME at the Eye Hospital, Univer...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbančič, Mojca, Klobučar, Pia, Zupan, Matej, Urbančič, Katja, Lavrič, Alenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125496/
https://www.ncbi.nlm.nih.gov/pubmed/32280530
http://dx.doi.org/10.1155/2020/6979758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125496/
https://www.ncbi.nlm.nih.gov/pubmed/32280530
http://dx.doi.org/10.1155/2020/6979758

Ejemplares similares